ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2203

Loss of Wdfy3 Leads to Enhanced Osteoclastogenesis Via NF-κB Activation

Dennis J. Wu1,2, Ran Gu2, Ritu Sarin2, Regina Zavodovskaya3, Chia-Pei Chen4, Konstantinos Zarbalis5,6 and Iannis E. Adamopoulos1,2,6, 1Graduate Group in Immunology, University of California, Davis, Davis, CA, 2Division of Rheumatology, Allergy and Clinical Immunology, University of California, Davis, Davis, CA, 3Department of Anatomy, Physiology and Cell Biology, University of California, Davis, Davis, CA, 4Department of Statistics, University of California, Davis, Davis, CA, 5Department of Pathology and Laboratory Medicine, University of California, Davis, Sacramento, CA, 6Institute for Pediatric Regenerative Medicine, Shriners Hospitals for Children, Northern California, Sacramento, CA

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: osteoclastogenesis and osteoclasts

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 10, 2015

Title: Biology and Pathology of Bone and Joint: Bone Remodeling and Metabolism

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Autophagy and phagocytosis are conserved cellular functions involved in the protein degradation process in immunity. Recently, autophagy-related proteins were shown to regulate osteoclast mediated bone resorption, a critical process in autoimmune diseases such as rheumatoid arthritis. Wdfy3 is a master regulator in selective autophagy for clearing ubiquitinated protein aggregates. In this study, we generated a series Wdfy3 transgenic mice (Wdfy3lacZ, and Wdfy3loxP) to investigate the function of Wdfy3 in osteoclast development and function.  

Methods: Wdfy3 expression in Wdfy3lacZ neonatal mice was analyzed by histology and X-gal staining. Bone marrow-derived macrophages from wild type, Wdfy3lacZ, and Wdfy3 conditional knockout (Wdfy3-cKO) mice (Wdfy3 loxP/loxP-LysM-Cre+) were differentiated into osteoclasts with macrophage colony-stimulating factor (M-CSF), and receptor activator of NF-κB ligand (RANKL). Wdfy3 expression on osteoclast-like cells was analyzed by X-gal staining and immunohistochemistry. RANKL-induced NF-κB signaling was analyzed by Western blot. Osteoclast-related genes Ctsk, Acp5, Mmp9 were measured by qPCR. Osteoclasts were characterized by tartrate-resistant acid phosphatase staining and filamentous actin ring formation assay. Osteoclast function was evaluated by dentin resorption assay.

Results: Our data showed that Wdfy3 is up regulated in osteoclasts in in vitro cultures and highly expressed at the growth plate of neonatal mice. Osteoclasts derived from Wdfy3-cKO, showed increased osteoclast differentiation and function as evidenced by higher number and enlarged size of TRAP+ multinucleated cells. Western blot analysis also revealed up-regulation of TRAF6, enhanced degradation of p-IκBα and increased p-NF-κB p65 in Wdfy3-deficient osteoclasts stimulated with RANKL compared to the control cells. Consistent with these observations Wdfy3 conditional knockout mice also showed an increase in osteoclast-related genes Ctsk, Acp5, Mmp9 and an increase of dentine resorption in in vitro assays. Importantly, no difference was observed in autophagic flux in Wdfy3 deficient bone marrow-derived macrophages and control cells at basal level or under starvation.

Conclusion: Taken together, our data highlight a novel role for Wdfy3 osteoclast development and function, which can be exploited for the treatment of musculoskeletal diseases.


Disclosure: D. J. Wu, None; R. Gu, None; R. Sarin, None; R. Zavodovskaya, None; C. P. Chen, None; K. Zarbalis, None; I. E. Adamopoulos, None.

To cite this abstract in AMA style:

Wu DJ, Gu R, Sarin R, Zavodovskaya R, Chen CP, Zarbalis K, Adamopoulos IE. Loss of Wdfy3 Leads to Enhanced Osteoclastogenesis Via NF-κB Activation [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/loss-of-wdfy3-leads-to-enhanced-osteoclastogenesis-via-nf-b-activation/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/loss-of-wdfy3-leads-to-enhanced-osteoclastogenesis-via-nf-b-activation/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology